[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"post-traumatic-olfactory-dysfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:post-traumatic-olfactory-dysfunction":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100629373","pandora-evaluation-of-platelet-rich-plasma-in-non-tumoural-odour-disorders-a-descriptive-pilot-study-100629373",false,"NCT07473830","PANDORA: Evaluation of Platelet-rich Plasma in Non-tumoural Odour Disorders: a Descriptive Pilot Study.","PANDORA","Inclusion Criteria\n\n* Adults with persistent (\\>6 months) non-tumoural olfactory dysfunction: age-related degenerative olfactory dysfunction (DOD) or post-traumatic olfactory dysfunction (DOPT).\n* Objective olfactory impairment confirmed by Sniffin' Sticks Test (TDI ≤ 30.5\u002F48).\n* MRI within the last 6 months after onset excluding tumoural etiology or central cause.\n* Normal nasal endoscopy.\n* Affiliated to a social security system (or equivalent).\n* Written informed consent.\n\nExclusion Criteria\n\n* Inflammatory rhinosinus disease (e.g., nasal polyposis) or granulomatosis with polyangiitis.\n* Coagulation disorder.\n* Brain radiotherapy history or ongoing chemotherapy.\n* Olfactory disorder temporally linked to SARS-CoV-2 infection (delay \\\u003C1 month).\n* History of sinus or skull base surgery (except septoplasty\u002Fturbinoplasty\u002Frhinoseptoplasty).\n* Therapeutic-dose anticoagulants.\n* Refusal to discontinue chronic NSAID use if applicable.\n* Pregnancy\u002Flabor\u002Fbreastfeeding.\n* Vulnerable persons (deprived of liberty; legal protection; etc.).\n* Participation in another interventional study with ongoing exclusion period.","ALL","18 Years","99 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a prospective, single-center, single-arm, non-comparative descriptive pilot study evaluating autologous platelet-rich plasma (PRP) injections in adults with persistent (\\>6 months) non-tumoural olfactory dysfunction, either age-related degenerative olfactory dysfunction (DOD) or post-traumatic olfactory dysfunction (DOPT). Participants receive three PRP injections over 4 weeks (Day 0, Day 14, Day 28), with follow-up visits at Month 3 and Month 6 after the first injection. Olfactory function is assessed using the Sniffin' Sticks Test (TDI score). Patient-reported outcomes include SNOT-22 and a visual analog scale (VAS) for perceived olfactory impairment. Safety is assessed through adverse event collection.",[27,28,29],"Olfactory Dysfunction","Post-traumatic Olfactory Dysfunction","Age-related Degenerative Olfactory Dysfunction",[31,32,33,34,35,36],"Platelet-rich plasma","PRP","Sniffin' Sticks","Olfactory cleft","Hyposmia","Anosmia","NOT_YET_RECRUITING","2026-03-17",{"date":40,"type":41},"2026-03-20","ACTUAL",{"date":43,"type":21},"2026-05",{"date":45,"type":21},"2028-05",{"name":47,"class":48},"Hospices Civils de Lyon","OTHER"]